Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
API
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
2. Atarax
3. Durrax
4. Hydroxyzine
5. Hydroxyzine Dihydrochloride
6. Hydroxyzine Hydrochloride
7. Orgatrax
8. Pamoate, Hydroxyzine
9. Vistaril
1. 10246-75-0
2. Hydroxyzine Embonate
3. Bobsule
4. Hydroxyzine (pamoate)
5. Equipose
6. Hydroxyzine Pamoate Salt
7. Hy-pam
8. Nsc-757063
9. Mls000028605
10. M20215mufr
11. Masmoran
12. Paxisitil
13. Smr000058728
14. Atarax P
15. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid;2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
16. Sr-01000003149
17. Einecs 233-582-1
18. Unii-m20215mufr
19. Hydroxyzine Pamoate [usp:jan]
20. Atarax-p (tn)
21. Spectrum_000911
22. Vistaril Pamoate (tn)
23. Spectrum2_001000
24. Spectrum3_000463
25. Spectrum4_000013
26. Spectrum5_000838
27. Hyydroxyzine Pamoate
28. 6-ethylthiomorpholin-3-one
29. Schembl41333
30. Bspbio_002166
31. Kbiogr_000385
32. Kbioss_001391
33. 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
34. Divk1c_000503
35. Spectrum1500345
36. Spbio_001099
37. Chembl1200467
38. Hydroxyzine Pamoate [mi]
39. Hms501j05
40. Kbio1_000503
41. Kbio2_001391
42. Kbio2_003959
43. Kbio2_006527
44. Kbio3_001386
45. Dtxsid00907580
46. Hydroxyzine Pamoate [jan]
47. Hydroxyzine Pamoate (jp17/usp)
48. Ninds_000503
49. Hms1920f11
50. Hms2091l19
51. Hms2235o19
52. Hms3886g14
53. Pharmakon1600-01500345
54. Hydroxyzine Pamoate [vandf]
55. Hy-b0895
56. Ccg-40218
57. Hydroxyzine Embonate [mart.]
58. Hydroxyzine Pamoate [usp-rs]
59. Mfcd00058051
60. Nsc757063
61. S5649
62. Hydroxyzine Embonate [who-dd]
63. Akos015914218
64. Nsc 757063
65. Idi1_000503
66. Hydroxyzine Pamoate [orange Book]
67. Ncgc00021152-02
68. Ncgc00021152-03
69. Ncgc00094698-01
70. Ncgc00094698-02
71. (+-)-2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
72. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, (+-)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)
73. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)
74. Hydroxyzine Pamoate [usp Monograph]
75. Sbi-0051413.p003
76. Ft-0697190
77. Hydroxyzine Pamoate Salt, Analytical Standard
78. D01096
79. F15112
80. J-000695
81. Sr-01000003149-2
82. Sr-01000003149-4
83. Q27114645
84. Hydroxyzine Pamoate, United States Pharmacopeia (usp) Reference Standard
85. (+/-)-2-(2-(4-(p-chloro-.alpha.-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
86. Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, (+/-)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)
Molecular Weight | 763.3 g/mol |
---|---|
Molecular Formula | C44H43ClN2O8 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 12 |
Exact Mass | 762.2707940 g/mol |
Monoisotopic Mass | 762.2707940 g/mol |
Topological Polar Surface Area | 151 Ų |
Heavy Atom Count | 55 |
Formal Charge | 0 |
Complexity | 945 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Hydroxyzine pamoate |
PubMed Health | Hydroxyzine Pamoate (By mouth) |
Drug Classes | Antianxiety, Antiemetic, Respiratory Agent |
Drug Label | Hydroxyzine pamoate is designated chemically as 1-(p-chlorobenzhydryl) 4-[2-(2-hydroxyethoxy) ethyl] diethylenediamine salt of 1,1'-methylene bis (2 hydroxy-3-naphthalene carboxylic acid). It has the following structural formula: C21H27ClN2O2C23H1... |
Active Ingredient | Hydroxyzine pamoate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 50mg hydrochloride; eq 50mg hcl; eq 100mg hcl; eq 25mg hcl; eq 25mg hydrochloride |
Market Status | Prescription |
Company | Sandoz; Watson Labs; Emcure Pharms Usa; Barr |
2 of 2 | |
---|---|
Drug Name | Hydroxyzine pamoate |
PubMed Health | Hydroxyzine Pamoate (By mouth) |
Drug Classes | Antianxiety, Antiemetic, Respiratory Agent |
Drug Label | Hydroxyzine pamoate is designated chemically as 1-(p-chlorobenzhydryl) 4-[2-(2-hydroxyethoxy) ethyl] diethylenediamine salt of 1,1'-methylene bis (2 hydroxy-3-naphthalene carboxylic acid). It has the following structural formula: C21H27ClN2O2C23H1... |
Active Ingredient | Hydroxyzine pamoate |
Dosage Form | Capsule |
Route | Oral |
Strength | eq 50mg hydrochloride; eq 50mg hcl; eq 100mg hcl; eq 25mg hcl; eq 25mg hydrochloride |
Market Status | Prescription |
Company | Sandoz; Watson Labs; Emcure Pharms Usa; Barr |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4629
Submission : 1982-08-11
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-28
Pay. Date : 2013-09-24
DMF Number : 4514
Submission : 1982-04-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3508
Submission : 1979-04-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2808
Submission : 1976-11-29
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-04
Pay. Date : 2024-08-13
DMF Number : 36954
Submission : 2022-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-09-07
Pay. Date : 2023-07-27
DMF Number : 38535
Submission : 2023-07-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3695
Submission : 1980-01-16
Status : Inactive
Type : II
Registration Number : 218MF11037
Registrant's Address : Via Colleoni 15/17, 24040 Ciserano(BG)・Italy
Initial Date of Registration : 2006-12-28
Latest Date of Registration : 2021-10-21
NDC Package Code : 51604-0004
Start Marketing Date : 2009-10-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1217
Start Marketing Date : 2022-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-2316
Start Marketing Date : 2013-06-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3659
Start Marketing Date : 1996-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13746-111
Start Marketing Date : 2012-10-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0122
Start Marketing Date : 2023-06-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49711-1508
Start Marketing Date : 2009-10-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Founded in 1977 and first inspected by FDA in 1984, COSMA SpA is the largest plant of the group and with over 130 m3 of reaction volume is focused on large-volume APIs. Brand new s...
About the Company : Fleming Laboratories Limited is in the business of manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) to the global Pharmaceutical Industry. ...
About the Company : Srikem is a trusted source of Active Pharmaceutical Ingredients (APIs) for top pharmaceutical companies around the world. The company was founded in the year 1994 and our founder M...
About the Company : Symed Labs Ltd is a leading Hyderabad based manufacturer of Active Pharmaceutical Ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemist...
About the Company : With over 85 years of experience, Uquifa provides comprehensive services supporting projects from proof of concept to commercial manufacturing. Uquifa’s business model is built o...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG HYDROCHLORIDE
Packaging :
Approval Date : 1982-01-01
Application Number : 86695
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25MG HYDROCHLORIDE
Packaging :
Approval Date : 1982-01-01
Application Number : 86698
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG HYDROCHLORIDE
Packaging :
Approval Date : 2013-06-03
Application Number : 201507
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG HYDROCHLORIDE
Packaging :
Approval Date : 1984-06-15
Application Number : 88487
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25MG HYDROCHLORIDE
Packaging :
Approval Date : 1991-06-28
Application Number : 81127
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25MG HYDROCHLORIDE
Packaging :
Approval Date : 1982-03-05
Application Number : 87761
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG HYDROCHLORIDE
Packaging :
Approval Date : 1986-03-17
Application Number : 89146
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VISTARIL
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG HYDROCHLORIDE
Packaging :
Approval Date : 1982-01-01
Application Number : 11459
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : HYDROXYZINE PAMOATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25MG HYDROCHLORIDE
Packaging :
Approval Date : 1982-01-01
Application Number : 87479
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HY-PAM "25"
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25MG HYDROCHLORIDE
Packaging :
Approval Date : 1985-03-04
Application Number : 88713
Regulatory Info : DISCN
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?